
Tisento Therapeutics’ Patient-Informed Phase 2 Trial is Advancing MELAS Research
Mitochondrial diseases represent some of medicine’s most complex research and treatment challenges. When mitochondria malfunction, the body’s ability to produce energy deteriorates. This causes cascading effects across organ systems. There are no approved treatments for MELAS, one of these rare disorders. But Tisento Therapeutics is working to change that.